| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T420 |
11-23 |
VBN |
denotes |
glycosylated |
| T421 |
23-24 |
-COMMA- |
denotes |
, |
| T422 |
25-29 |
IN |
denotes |
with |
| T423 |
30-34 |
NNP |
denotes |
SARS |
| T424 |
35-38 |
CC |
denotes |
and |
| T425 |
39-43 |
NNP |
denotes |
MERS |
| T426 |
44-45 |
NN |
denotes |
S |
| T427 |
46-59 |
NNS |
denotes |
glycoproteins |
| T428 |
60-64 |
CC |
denotes |
both |
| T429 |
65-73 |
VBG |
denotes |
encoding |
| T430 |
74-76 |
CD |
denotes |
69 |
| T431 |
77-85 |
JJ |
denotes |
N-linked |
| T432 |
86-92 |
NN |
denotes |
glycan |
| T433 |
93-100 |
NNS |
denotes |
sequons |
| T434 |
101-104 |
IN |
denotes |
per |
| T435 |
105-113 |
JJ |
denotes |
trimeric |
| T436 |
114-119 |
NN |
denotes |
spike |
| T437 |
120-124 |
IN |
denotes |
with |
| T438 |
125-135 |
NN |
denotes |
SARS-CoV-2 |
| T439 |
136-146 |
VBG |
denotes |
containing |
| T440 |
147-149 |
CD |
denotes |
66 |
| T441 |
150-155 |
NNS |
denotes |
sites |
| T442 |
157-162 |
DT |
denotes |
These |
| T443 |
163-176 |
NNS |
denotes |
modifications |
| T444 |
177-182 |
RB |
denotes |
often |
| T445 |
183-187 |
VBP |
denotes |
mask |
| T446 |
188-199 |
JJ |
denotes |
immunogenic |
| T447 |
200-207 |
NN |
denotes |
protein |
| T448 |
208-216 |
NNS |
denotes |
epitopes |
| T449 |
217-221 |
IN |
denotes |
from |
| T450 |
222-225 |
DT |
denotes |
the |
| T451 |
226-230 |
NN |
denotes |
host |
| T452 |
231-238 |
JJ |
denotes |
humoral |
| T453 |
239-245 |
JJ |
denotes |
immune |
| R417 |
T420 |
T421 |
arg1Of |
glycosylated,"," |
| R418 |
T420 |
T422 |
arg1Of |
glycosylated,with |
| R419 |
T427 |
T422 |
arg2Of |
glycoproteins,with |
| R420 |
T427 |
T423 |
arg1Of |
glycoproteins,SARS |
| R421 |
T423 |
T424 |
arg1Of |
SARS,and |
| R422 |
T425 |
T424 |
arg2Of |
MERS,and |
| R423 |
T427 |
T425 |
arg1Of |
glycoproteins,MERS |
| R424 |
T427 |
T426 |
arg1Of |
glycoproteins,S |
| R425 |
T429 |
T428 |
arg1Of |
encoding,both |
| R426 |
T427 |
T429 |
arg1Of |
glycoproteins,encoding |
| R427 |
T433 |
T429 |
arg2Of |
sequons,encoding |
| R428 |
T433 |
T430 |
arg1Of |
sequons,69 |
| R429 |
T433 |
T431 |
arg1Of |
sequons,N-linked |
| R430 |
T433 |
T432 |
arg1Of |
sequons,glycan |
| R431 |
T433 |
T434 |
arg1Of |
sequons,per |
| R432 |
T436 |
T434 |
arg2Of |
spike,per |
| R433 |
T436 |
T435 |
arg1Of |
spike,trimeric |
| R434 |
T436 |
T437 |
arg1Of |
spike,with |
| R435 |
T438 |
T437 |
arg2Of |
SARS-CoV-2,with |
| R436 |
T438 |
T439 |
arg1Of |
SARS-CoV-2,containing |
| R437 |
T441 |
T439 |
arg2Of |
sites,containing |
| R438 |
T441 |
T440 |
arg1Of |
sites,66 |
| R439 |
T443 |
T442 |
arg1Of |
modifications,These |
| R440 |
T445 |
T444 |
arg1Of |
mask,often |
| R441 |
T443 |
T445 |
arg1Of |
modifications,mask |
| R442 |
T448 |
T445 |
arg2Of |
epitopes,mask |
| R443 |
T448 |
T446 |
arg1Of |
epitopes,immunogenic |
| R444 |
T448 |
T447 |
arg1Of |
epitopes,protein |
| R445 |
T448 |
T449 |
arg1Of |
epitopes,from |
